Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal (opens in new tab)

Merck KGaA's agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy. The post appeared first on .